• Profile
Close

Intranasal ketamine reduces pain of digital nerve block; a double-blind randomized clinical trial

The American Journal of Emergency Medicine Nov 22, 2018

Nejati A, et al. - Researchers sought the efficacy of IN ketamine in acute pain management in the Emergency Department (ED) via performing a double blind randomized clinical trial on patients older than 15 years who needed digital nerve block (DNB); IN Ketamine (1 ml = 50 mg) or placebo (normal saline, 1 ml) 5 min before DNB was administered to participants randomly. Outcomes suggest a potential efficacy of IN ketamine in reducing pain in patients with acute pain, without adding significant side effects.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay